NCI Designated Cancer Center
Winship Cancer Institute of Emory University
Winship Cancer Institute of Emory University is Georgia's first and only cancer
center designated by the National Cancer Institute (NCI). Designation requires meeting
rigorous criteria for the depth and breadth of basic science and clinical research,
in addition to cancer prevention, control, and population/behavioral sciences. Designation
requires effective collaboration among various disciplines and with community partners
in private practice and in academic centers throughout Georgia and across the nation.
With this recognition comes the responsibility to provide public information, education
and outreach to other health care professionals and the community. NCI designation
for Winship gives Georgians improved access to clinical trials and resources that
may not be available elsewhere.
The Winship Cancer Institute (Winship) at Emory University is a multidisciplinary
matrix center that supports, facilitates, coordinates, and centralizes cancer research,
quality oncology care, education, and dissemination at Emory University and its
affiliate institutions in order to reduce the burden of cancer, associated morbidity,
and mortality in the state of Georgia, the Southeastern region, and the U.S. Winship
is dedicated to the integration of innovative clinical and basic science research
with outstanding patient care for the prevention, treatment and control of cancer.
NCI Designated Program
Georgia Regents University
Minority Based Community Clinical Oncology Program (MB-CCOP)
The Georgia Regents University (GRU) Minority-Based Community Clinical
Oncology Program (MB-CCOP) is designed to increase the availability of state-of-the-art
cancer treatment and research to minority individuals in their own communities.
Establishment of an operational base in this part of Georgia for extending cancer
clinical trials and cancer prevention aims to reduce cancer incidence, morbidity,
and mortality in minority populations.
The program was created by the National Cancer Institute (NCI) in 1983 and awarded
to Georgia Regents University (formerly known as the Medical College of
Georgia or MCG) in August of 2004. The principal investigator is Anand P. Jillella,
MD. The Grant describes the organizational and operational plans intended to provide
structure for the effective implementation of multidisciplinary research. African-Americans
comprise 42% of newly diagnosed cancer patients at GRU. Adult and pediatric cancer
clinical trial programs at GRU have been successfully enrolling minorities to clinical
trials (40% of patients entered are African-Americans). Ultimately, success of the
MB-CCOP depends upon the joint efforts of three departments at the Georgia Regents University: Adult Hematology/Oncology, Pediatric Hematology/Oncology, and
Research & Clinical Trials
Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) at St. Joseph's/Candler
NCI Community Cancer Centers Program (NCCCP)
The National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) is
a network of hospital cancer centers that serve as a community-based platform to
support basic, clinical, and population-based research initiatives across the cancer
care continuum—from prevention, screening, diagnosis, treatment, and survivorship
through end-of-life care. One of the goals of the NCCCP is to increase access to
clinical trials in a community setting. Through a strategic partnership between
the NCI and participating hospitals, the NCCCP is a hospital-based cancer center
network designed to support cancer research, and enhance access to and increase
quality of care at community hospitals so more patients benefit from the latest
The Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) was one of the
first of ten health systems selected by the NCCCP in 2007 to participate in what
was originally a pilot program. It has since grown to a full-fledged program with
30 locations. As a National Cancer Institute NCCCP site, clinical research is one
of the top goals of the LCRP. Every month the LCRP initiates several new clinical
trials and anticipates having trials to offer patients with virtually every type
and stage of cancer. Scientific breakthroughs lead to positive changes in the fight
against cancer, and these trials will assist the LCRP in its dedication to deliver
the best level of patient care in their own community.
NCI Designated Program
Northside Hospital Cancer Institute
National Community Cancer Center Program (NCCCP)
Northside Hospital Cancer Institute is among the 30 sites chosen by the National
Cancer Institute, part of the National Institutes of Health, to join a national
network of community cancer centers offering expanded research opportunities and
state-of-the-art cancer care. The National Cancer Institute Community Cancer Centers
Program (NCCCP) is working to bring the latest scientific advances and evidence-based
care within easy reach of cancer patients in underserved rural, suburban and inner-city
locations across the United States.
The NCCCP hospitals provide care spanning the cancer continuum – from prevention,
screening, diagnoses, treatment and survivorship. The primary benefits for the patients
and the community are:
- Care Close to Home: for many cancer patients the best cancer care and access to
clinical trials is simply out of reach because it requires too much travel and time
away from family and jobs. The NCCCP was founded on the principle that patients
should not have to travel to receive the highest level of cancer care.
- Nurse Navigators: help to guide the patient and family through the healthcare system.
- Clinical Trials: patients at NCCCP hospitals have greater opportunities to participate
in clinical trials and access to enhanced screening, palliative care and other services.